The pharmaceutical industry stands at an inflection point where artificial intelligence is fundamentally reshaping how healthcare providers access information, make treatment decisions, and engage with pharmaceutical brands. The DHC Group’s recent webinar, featuring new research of 160 U.S. physicians from the Sermo Realtime Network and insights from five industry experts, revealed that AI adoption among HCPs has accelerated beyond anyone’s predictions—and pharmaceutical marketers must adapt quickly.